Department of Anesthesiology and Pain Medicine, 65409Chungnam National University Hospital, Daejeon, Korea.
Department of Anesthesiology and Pain Medicine, College of Medicine, 26715Chungnam National University, Daejeon, Korea.
J Orthop Surg (Hong Kong). 2021 Jan-Apr;29(1):23094990211000142. doi: 10.1177/23094990211000142.
Continuous interscalene brachial plexus block (CISB) is well known to reduce postoperative pain and to improve patient satisfaction. However, the effect of CISB on the quality of postoperative recovery is unknown. We Compared the quality of recovery from arthroscopic rotator cuff repair in patients who received CISB or single interscalene brachial plexus block (SISB).
This prospective non-randomized controlled trial with propensity score matching enrolled 134 patients undergoing arthroscopic surgery for rotator cuff repair. Each patient received an interscalene block before surgery. One group had a catheter insertion 30 min after the end of surgery and started patient-controlled regional analgesia (PCRA, n = 49). The other group received intravenous patient-controlled analgesia (IV-PCA, n = 85). The primary outcome was the quality of recovery (QoR-40) score. Also, postoperative analgesia, sleep quality, and postoperative complications were evaluated.
The two groups had similar QoR-40 score on postoperative day-1 (POD1), but the PCRA group had a significantly greater QoR-40 score on POD2 (156.0, IQR: 143.0, 169.0 171.0, IQR: 159.0, 178.0; < 0.001). The IV-PCA group received more analgesics during the 2 days after surgery, especially during night-time, and had a higher prevalence of sleep disturbances. The time to first additional analgesics request was significantly longer in PCRA group (14 hours, 95% CI: 13-16 44 hours, 95% CI: 28-not applicable). The incidence of postoperative nausea and vomiting significantly lower in the PCRA group (16.3% vs 46.9%, p = 0.002).
CISB showed a higher quality of recovery score than SISB with IV-PCA in arthroscopic rotator cuff repair, probably related to the effective analgesia, improved sleep quality, and reduced opioid-related complications.
连续锁骨下臂丛神经阻滞(CISB)已被证实可减轻术后疼痛并提高患者满意度。然而,CISB 对术后恢复质量的影响尚不清楚。我们比较了接受 CISB 或单次锁骨下臂丛神经阻滞(SISB)的关节镜肩袖修复患者的术后恢复质量。
本前瞻性非随机对照试验采用倾向评分匹配纳入 134 例接受关节镜下肩袖修复术的患者。每位患者在手术前均接受锁骨下阻滞。一组在手术结束后 30 分钟插入导管,并开始患者自控区域镇痛(PCRA,n=49)。另一组接受静脉患者自控镇痛(IV-PCA,n=85)。主要结局是恢复质量(QoR-40)评分。还评估了术后镇痛、睡眠质量和术后并发症。
两组患者在术后第 1 天(POD1)的 QoR-40 评分相似,但 PCRA 组在术后第 2 天(POD2)的 QoR-40 评分显著更高(156.0,IQR:143.0,169.0;171.0,IQR:159.0,178.0;<0.001)。IV-PCA 组在术后 2 天内需要更多的镇痛药,特别是在夜间,且睡眠障碍的发生率更高。PCRA 组首次需要额外镇痛药物的时间明显更长(14 小时,95%CI:13-16;44 小时,95%CI:28-无)。PCRA 组术后恶心呕吐的发生率显著较低(16.3%比 46.9%,p=0.002)。
与 IV-PCA 相比,CISB 用于关节镜肩袖修复术可获得更高的恢复质量评分,可能与有效镇痛、改善睡眠质量和减少阿片类药物相关并发症有关。